U.S. President Donald Trump announced Friday that nine drugmakers have agreed to lower the cost of their prescription drugs in the U.S. Amgen, Bristol Myers Squibb, Boehringer Ingelheim, Genentech, Gilead...
Officials say the U.K. has sealed a deal securing a 0% tariff rate for all U.K. medicines exported to the U.S. for at least three years, in return for the U.K. spending more on new medicine
President Donald Trump has unveiled a deal with drugmakers Eli Lilly and Novo Nordisk to expand coverage and reduce prices for their popular obesity treatments Zepbound and Wegovy
Continued strong commercial performance and unprecedented pipeline delivery in the year to date
AstraZeneca has agreed to lower prescription drug costs for Medicaid under a deal with the Trump administration
President Donald Trump is putting import taxes of 100% on pharmaceutical drugs, 50% on kitchen cabinets and bathroom vanities, 30% on upholstered furniture and 25% on heavy trucks starting on Oct. 1
The Trump administration has issued its first warnings to online services that offer unofficial versions of popular drugs like the blockbuster obesity treatment Wegovy
What lessons does value investing’s success abroad hold for value investors everywhere
Strong growth momentum continues with excellent R&D pipeline delivery in the year-to-date
